Xcout Intel
Orchard Therapeutics plc
Orchard Therapeutics plc is a biopharmaceutical company with operations including a U.S. headquarters located in Boston, Massachusetts.
Subscribe to see Orchard Therapeutics plc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Orchard Therapeutics plc at a glance
Orchard Therapeutics plc is a biotech company headquartered in United Kingdom, founded in 2015. It has raised at least $334M across the 3 funding rounds on record. Its most recent funding round raised $34M in March 2023. Xcout tracks 3 named people at Orchard Therapeutics plc, including Adrian Thrasher (Scientific Founder). Xcout recorded 3 job postings from Orchard Therapeutics plc in the last 90 days.
Orchard Therapeutics plc leadership
- Adrian ThrasherScientific Founder
- Bobby GasparScientific Founder
- Donald KohnScientific Founder
Orchard Therapeutics plc funding rounds
At least $334M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $34M | — | |
| SEC Form D filing | $150M | — | |
| Series C | $150M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Orchard Therapeutics plc
Xcout recorded 3 job postings from Orchard Therapeutics plc in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Orchard Therapeutics plc's hiring signals →
Orchard Therapeutics plc competitors
A few of Orchard Therapeutics plc's closest competitors — see the full list of competitors and alternatives →
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Amicus Therapeutics, Inc. is an American biopharmaceutical company focused on discovering and delivering advanced therapies for rare diseases. The company is publicly traded on Nasdaq and maintains its global corporate headquarters in Princeton, New Jersey.
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
Rinascera Therapeutics, Inc. is a clinical-stage biotechnology company located in Boston, Massachusetts, dedicated to transforming the treatment of rare genetic skin diseases.
Pretzel Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, advancing a new class of medicines that target cellular energetics and mitochondrial function.
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Get Orchard Therapeutics plc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Orchard Therapeutics plc in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access